![Dirk Kersten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Kersten
Director/Board Member at
DYNE THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2026
Profile
Dirk Kersten is currently serving as a Director at NorthSea Therapeutics BV, an Independent Director at Dyne Therapeutics, Inc., a Director at Synox Therapeutics Ltd., and a Managing Partner at Forbion Capital Partners Management Holding BV.
Previously, he held positions as a Director at GTx, Inc., Audion Therapeutics BV, Ascendis Pharma A, Profibrix BV, INKEF Capital BV (where he served as Managing Director from 2014 to 2018), NightBalance BV, Lanthio Pharma BV, and ViCentra BV.
He also worked as a Partner at Gilde Healthcare Partners, Inc. from 2011 to 2014.
Mr. Kersten obtained a graduate degree from the University of Groningen.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Dirk Kersten active positions
| Companies | Position | Start |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Director/Board Member | 01/11/2018 |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Private Equity Investor | 01/10/2018 |
Synox Therapeutics Ltd.
 Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Director/Board Member | - |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Director/Board Member | - |
Former positions of Dirk Kersten
| Companies | Position | End |
|---|---|---|
INKEF Capital BV
 INKEF Capital BV Investment ManagersFinance INKEF Capital invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 01/09/2018 |
Gilde Healthcare Partners, Inc.
 Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Chief Executive Officer | 01/05/2014 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Director/Board Member | - |
NightBalance BV
 NightBalance BV Medical DistributorsDistribution Services Develops and markets sensor-devices for the treatment of sleep apnea | Director/Board Member | - |
Lanthio Pharma BV
 Lanthio Pharma BV Medical SpecialtiesHealth Technology Focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics | Director/Board Member | - |
Training of Dirk Kersten
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
Audion Therapeutics BV
 Audion Therapeutics BV Pharmaceuticals: MajorHealth Technology Discovers and deveops of drugs | Health Technology |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
NightBalance BV
NightBalance BV Medical DistributorsDistribution Services Develops and markets sensor-devices for the treatment of sleep apnea | Distribution Services |
Lanthio Pharma BV
Lanthio Pharma BV Medical SpecialtiesHealth Technology Focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics | Health Technology |
Gilde Healthcare Partners, Inc.
Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
ViCentra BV
 ViCentra BV Medical SpecialtiesHealth Technology Manufactures insulin pumps | Health Technology |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Dirk Kersten
